Conversely, SSc-ILD patients showed a 6.08% annual reduction in lung volume (already low at baseline), lower CT densitometry values across slices, and an increase in galectin-3—suggestive of progressive pulmonary fibrosis rather than renal involvement. Here, LGALS3 is linked to systemic sclerosis.